The dominant presence in some of the pharma intermediate molecules. ‘Europe plus one’ is taking traction for Chemicals. Multi-year contract with Fermion for one of its patented products. Gained traction in the electrolyte additives business. Gradual pickup in pharma demand after a recent lull. In specialty chemicals, company is expanding on the clientele side.
first published: Mar 21, 2023 11:54 am
A collection of the most-viewed Moneycontrol videos.
Live: Sensex, Nifty fall 1% amidst broad-based selloff | Closing Bell
Live: Can Nifty reclaim record levels as investors await FOMC decision this week? | Opening Bell
Why This Tenant Says Bandra Is Better Than California | The Tenant
Nifty Clocks Triple-Digit Gains After RBI Rate Cut But Logs Losses For The Week| Closing Bell Live
